Advertisement
Original article Experimental endoscopy| Volume 76, ISSUE 6, P1197-1206.e5, December 2012

Download started.

Ok

Near-infrared-labeled peptide multimer functions as phage mimic for high affinity, specific targeting of colonic adenomas in vivo (with videos)

Published:October 01, 2012DOI:https://doi.org/10.1016/j.gie.2012.07.017

      Background

      Fluorescent-labeled peptides are being developed to improve the endoscopic detection of colonic dysplasia.

      Objective

      To demonstrate a near-infrared peptide multimer that functions as a phage mimic for in vivo detection of colonic adenomas.

      Design

      A peptide multimer was synthesized by using trilysine as a dendritic wedge to mimic the presentation of peptides on phage, and all peptides, including the multimer, were fluorescent-labeled with Cy5.5.

      Setting

      Small-animal imaging facility.

      Animal Subjects

      Genetically engineered CPC;Apc mice that spontaneously develop colonic adenomas.

      Intervention

      Near-infrared-labeled AKPGYLS peptide multimer was administered topically into the distal colons of the mice, and endoscopic images of adenomas were captured. Fluorescence intensities were quantified by target-to-background (T/B) ratios, and adenoma dimensions were measured with calipers after imaging. Validation of specific peptide binding was performed on cryosectioned specimens and cells by using confocal microscopy and flow cytometry.

      Main Outcome Measurements

      Fluorescence T/B ratios from colonic adenomas and adjacent normal-appearing mucosa.

      Results

      AKP-multimer, monomer, trilysine core, and Cy5.5 resulted in mean (± SD) T/B ratios of 3.85 ± 0.25, 2.21 ± 0.13, 1.56 ± 0.12, and 1.19 ± 0.11, respectively, P < .01 on in vivo imaging. Peptide multimer showed higher contrast and greater specificity for dysplastic crypts as compared with other probes. Peptide multimer demonstrated significantly greater binding to HT29 cells on flow cytometry and fluorescence microscopy in comparison to monomer and trilysine core. A binding affinity of 6.4 nm/L and time constant of 0.1136 minutes−1 (8.8 minutes) was measured for multimer.

      Limitations

      Only distal colonic adenomas were imaged.

      Conclusion

      Peptide multimers combine strengths of multiple individual peptides to enhance binding interactions and demonstrate significantly higher specificity and affinity for tumor targets.

      Abbreviations:

      FITC (fluorescein isothiocyanate), HPLC (high-performance liquid chromatography), NIR (near-infrared), PBS (phosphate-buffered saline), T/B (target-to-background), TFA (trifluoroacetic acid)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zauber A.G.
        • Winawer S.J.
        • O'Brien M.J.
        • et al.
        Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.
        N Engl J Med. 2012; 366: 687-696
        • Baxter N.N.
        • Goldwasser M.A.
        • Paszat L.M.
        • et al.
        Association of colonoscopy and death from colorectal cancer.
        Ann Intern Med. 2009; 150: 1-8
        • Lakoff J.
        • Paszat L.F.
        • Saskin R.
        • et al.
        Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study.
        Clin Gastroenterol Hepatol. 2008; 6: 1117-1121
        • Singh H.
        • Nugent G.
        • Demers A.A.
        • et al.
        The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer.
        Gastroenterology. 2010; 139: 1128-1137
        • Heresbach D.
        • Barrioz T.
        • Lapalus M.G.
        • et al.
        Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies.
        Endoscopy. 2008; 40: 284-290
        • O'Brien M.J.
        • Winawer S.J.
        • Zauber A.G.
        • et al.
        • National Polyp Study Workgroup
        Flat adenomas in the National Polyp Study: Is there increased risk for high-grade dysplasia initially or during surveillance?.
        Clin Gastroenterol Hepatol. 2004; 2: 905-911
        • Goetz M.
        • Wang T.D.
        Molecular imaging in gastrointestinal endoscopy.
        Gastroenterology. 2010; 138: 828-833
        • Joshi B.P.
        • Wang T.D.
        Exogenous molecular probes for targeted imaging in cancer: focus on multi-modal imaging.
        Cancers. 2010; 2: 1251-1287
        • Molek P.
        • Strukelj B.
        • Bratkovic T.
        Peptide phage display as a tool for drug discovery: targeting membrane receptors.
        Molecules. 2011; 16: 857-887
        • Liu S.
        Radiolabeled cyclic RGD peptides as integrin αvβ3-targeted radiotracers: maximizing binding affinity via bivalency.
        Bioconjugate Chem. 2009; 20: 2199-2213
        • Handl H.L.
        • Vagner J.
        • Han H.
        • et al.
        Hitting multiple targets with multimeric ligands.
        Expert Opin Ther Targets. 2004; 8: 565-586
        • Kiessling L.L.
        • Gestwicki J.E.
        • Strong L.E.
        Synthetic multivalent ligands in the exploration of cell-surface interactions.
        Curr Opin Chem Biol. 2000; 4: 696-703
      1. Liu Z, Miller SJ, Joshi BP, et al. In vivo targeting of colonic dysplasia on fluorescence endoscopy with near-infrared octapeptide. Gut. Epub 2012 Mar 17.

        • Miller S.J.
        • Lee C.M.
        • Joshi B.P.
        • et al.
        Targeted detection of murine colonic dysplasia in vivo with flexible multi-spectral scanning fiber endoscopy.
        J Biomed Opt. 2012; 17: 021103
        • Hinoi T.
        • Akyol A.
        • Theisen B.K.
        • et al.
        Mouse model of colonic adenoma-carcinoma progression based on somatic apc inactivation.
        Cancer Res. 2007; 67: 9721-9730
        • Fields G.B.
        • Noble R.L.
        Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids.
        Int J Pept Protein Res. 1990; 35: 161-214
        • Miller S.J.
        • Joshi B.P.
        • Gaustad A.
        • et al.
        In vivo fluorescence-based endoscopic detection of colon dysplasia in the mouse using a novel peptide probe.
        PLoS One. 2011; 6: e17384
        • Li M.
        • Anastassiades C.P.
        • Joshi B.
        • et al.
        Affinity peptide for targeted detection of dysplasia in Barrett's esophagus.
        Gastroenterology. 2010; 139: 1472-1480
        • Oyama T.
        • Sykes K.F.
        • Samli K.N.
        • et al.
        Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents.
        Cancer Lett. 2003; 202: 219-230
        • Goetz M.
        • Ziebart A.
        • Foersch S.
        • et al.
        In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor.
        Gastroenterology. 2010; 138: 435-446
        • Alencar H.
        • Funovics M.A.
        • Figueiredo J.
        • et al.
        Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection-study in mice.
        Radiology. 2007; 244: 232-238
        • Diaz J.E.
        • Howard B.E.
        • Neubauer M.S.
        • et al.
        Exploring biochemistry and cellular biology with protein libraries.
        Curr Issues Mol Biol. 2003; 5: 129-146
        • Kim Y.
        • Lillo A.M.
        • Steiniger S.C.
        • et al.
        Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand.
        Biochemistry. 2006; 45: 9434-9444
        • Jager S.
        • Jahnke A.
        • Wilmes T.
        • et al.
        Leukemia targeting ligands isolated from phage displayed peptide libraries.
        Leukemia. 2007; 21: 411-420
        • Kelly K.
        • Alencar H.
        • Funovics M.
        • et al.
        Detection of invasive colon cancer using a novel, targeted, library derived fluorescent peptide.
        Cancer Res. 2004; 64: 6247-6251
        • Zhang X.
        • Xiong Z.
        • Wu Y.
        • et al.
        Quantitative PET imaging of tumor integrin αvβ3 expression with 18F-FRGD2.
        J Nucl Med. 2006; 47: 113-121
        • Liu S.
        • Edwards D.S.
        • Ziegler M.C.
        • et al.
        99mTc-labeling of a hydrazinonicotinamide-conjugated vitronectin receptor antagonist useful for imaging tumors.
        Bioconjug Chem. 2001; 12: 624-629
        • Janssen M.L.
        • Oyen W.J.
        • Dijkgraaf I.
        • et al.
        Tumor targeting with radiolabeled αvβ3 integrin binding peptides in a nude mouse model.
        Cancer Res. 2002; 62: 6146-6151
        • Li Z.B.
        • Cai W.
        • Cao Q.
        • et al.
        64Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v) beta(3) integrin expression.
        J Nucl Med. 2007; 48: 1162-1171
        • Jasperson K.W.
        • Tuohy T.M.
        • Neklason D.W.
        • et al.
        Hereditary and familial colon cancer.
        Gastroenterology. 2010; 138: 2044-2058
        • Ahmadi A.
        • Polyak S.
        • Draganov P.V.
        Colorectal cancer surveillance in inflammatory bowel disease: the search continues.
        World J Gastroenterol. 2009; 15: 61-66

      Supplement references

        • Shangguan D.
        • Li Y.
        • Tang Z.
        • et al.
        Aptamers evolved from live cells as effective molecular probes for cancer study.
        Proc Natl Acad Sci USA. 2006; 103: 11838-11843
        • Thomas R.
        • Chen J.
        • Roudier M.M.
        • Vessella R.L.
        • Lantry L.E.
        • Nunn A.D.
        In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues.
        Clin Exp Metastasis. 2009; 26: 105-119